MBOT
Microbot Medical Inc is a pre-clinical medical device company. It specializes in research, design and development of next generation micro-robotics assisted medical technologies.
Microbot Medical Inc. (MBOT) is rated C (2.3/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (B); its weakest is Momentum (D). The rating has held at C for 13 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-13 | D+ (1.7) | B (3.3) | C (2.4) | D (1.5) | C+ (2.6) | C (2.3) |
| 2026-11-06 | D+ (1.7) | B (3.3) | C (2.4) | D (1.2) | C+ (2.7) | C (2.3) |
| 2026-10-30 | D+ (1.7) | B (3.2) | C (2.2) | D (1.4) | C+ (2.7) | C (2.2) |
| 2026-10-23 | C+ (2.8) | B (3.3) | C (2.2) | D (1.2) | C+ (2.6) | C (2.4) |
| 2026-10-16 | C+ (2.8) | B (3.3) | C (2.2) | D (1.2) | C+ (2.6) | C (2.4) |